Article info

Download PDFPDF

Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial

Authors

  1. a +1 313-576-8718 vaishamu{at}karmanos.org
View Full Text

Citation

Vaishampayan U, Schöffski P, Ravaud A, et al
Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial

Publication history

  • Received May 31, 2019
  • Accepted September 20, 2019
  • First published October 24, 2019.
Online issue publication 
October 24, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.